Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
filingDate |
1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2002-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002516874-A |
titleOfInvention |
Recombinant human interferon β-1A (IFN-β-1A) formulation |
abstract |
(57) [Summary]nA liquid composition comprising a buffer having a pH of about 7.2, recombinant interferon-beta and 15 mg / ml human serum albumin, and a kit for parenteral administration comprising the composition. |
priorityDate |
1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |